An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
Clinical trial NCT04476446 · COMPLETED
Trial details
- NCT number
- NCT04476446
- Sponsor
- Janssen-Cilag, S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-08
- Primary completion
- 2023-06-16
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.